Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546
info@example.com

Related Posts

Products

Anti-JKa

The Kidd antigen system consists of 2 antigens: JKa and JKb, which were first reported in 1951 and 1953 respectively. Kidd antibodies are capable of causing severe acute haemolytic transfusion reactions and haemolytic disease of the fetus and new-born. They are unique in that they are capable of dropping to low or even undetectable levels. This Anti-JKa and Anti-JKreagent is for the in vitro detection and identification of the human JKa and JKb blood group antigens respectively, by direct agglutination.

The Biorex Diagnostics Anti-JKa and Anti-JKb blood grouping reagents contain human monoclonal IgM antibodies, diluted in a phosphate buffer containing sodium chloride and bovine albumin. Anti-JKis manufactured with Clone P3HT7 and Anti-JKb with Clone P3143. This reagent is supplied ready for use and does not require any further dilution or addition.

Add to Quote

Description

Product Name CAT.No Size
Anti-JKa BGJKA002 1 x 2ml

 

 

Product Description

The Biorex Diagnostics Anti-JKa reagent is a ready-to-use monoclonal IgM solution for the accurate detection of the JKa antigen within the Kidd blood group system. Kidd antibodies are clinically significant and are known for causing delayed and acute haemolytic transfusion reactions (HTRs) as well as haemolytic disease of the foetus and newborn (HDFN), making reliable JKa typing essential for transfusion safety.

Key Features
• Accurate detection of JKa antigen – supports transfusion compatibility testing
• Clinically significant – helps prevent HTRs and manage HDFN risk
• Monoclonal IgM formulation – ensures clear, reliable agglutination results
• Ready-to-use format – no dilution or preparation required
• Supports extended phenotyping – used alongside Anti-JKb for full Kidd system typing

Benefits
Routine use enhances safety in blood transfusion by ensuring correct identification of JKa-positive and negative donor units. Its stability, ease of use, and consistent reactivity improve workflow in hospitals, blood banks, and specialist immunohaematology laboratories, supporting confident decision-making in patient care, antenatal screening, and complex antibody investigations.

Additional information

Storage

2-8°C